Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 17.68 |
| Open | 18.21 |
| Bid | 17.84 x 100 |
| Ask | 17.88 x 100 |
| Day's Range | 17.64 - 18.59 |
| 52 Week Range | 10.65 - 22.09 |
| Volume | |
| Avg. Volume | 370,024 |
| Market Cap | 1.267B |
| Beta (5Y Monthly) | 0.30 |
| PE Ratio (TTM) | 137.38 |
| EPS (TTM) | 0.13 |
| Earnings Date | Jul 23, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.75 |
Simply Wall St.Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
Insider MonkeyKiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
- GuruFocus.com
Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts
Strong Revenue Growth Amidst Increased Operating Expenses
© 2024 Yahoo. All rights reserved.